June 2014 Issue of The Ophthalmologist

At last, a unique and useful function for femtosecond laser systems has emerged.

The visual cortex processes auditory information – both real and imaginary

The body’s own regulatory T-lymphocytes, known as Tregs, can be taught to douse inflammation.

Common yoga positions significantly raise IOP for prolonged periods

Purchase of the ex-US rights for Fovista is costing Novartis US$200 million down and up to a cool US$1 billion in milestone payments

Valeant and Allergan continue to joust, Santen purchases MSD’s ophthalmology drug portfolio in selected markets, and Kala completes a US$22.5 million Series B financing round

In August, The Ophthalmologist will publish a special issue showcasing the very best images from the field of ophthalmology.

A head-mounted iPhone-based ophthalmoscope is the latest step in the rapidly evolving world of smartphone fundoscopy

Big data analytics is the most sophisticated method yet devised for “augmenting the human intellect”.

With childhood vision disorders like amblyopia and strabismus, early diagnosis is the key to treatment success.

Concomitant ocular diseases present an increasingly common challenge.

What does analysis of the last five years of the literature on keratoconus tell us about the priorities of the field and the major contributors to it?

Dramatic improvements in the results from an astigmatic keratotomy model suggest that the femtosecond laser may be more than a rich ophthalmologist’s toy after all.

Diabetic maculopathy is the most common cause of visual impairment in individuals with diabetes.

Diabetic macular edema (DME) may occur when blood vessels leak contents into the macular region.

Diabetic macular edema (DME) poses a significant management dilemma for visual impairment.

As the prevalence of diabetes increases worldwide, so too do the complications relating to it, such as diabetic macular edema (DME).

One of the most debilitating microvascular complications of diabetes is diabetic retinopathy, the most important cause of blindness among working age adults in developed countries.

Sitting Down With Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.